Qualitative Concept – Page 49

Suzetrigine, Non-opioid pain drug, Acute pain management, FDA approval, Vertex Pharmaceuticals, NaV1.8 pain signal inhibitor, Opioid epidemic, Pain relief without addiction risk

Vertex’s Non-Opioid Pain Drug, Suzetrigine (VX-548), Shows Promising Results in Phase III Trials, Aiming for FDA Approval

11 months ago talkbio0Tagged Acute onset pain, Approved, non-opioid pain drug, Opioids, Phase 3 Clinical Trials, Suzetrigine, United States Food and Drug Administration, VX-548

Non-opioid pain drug, Suzetrigine (VX-548), Vertex Pharmaceuticals, Phase III trials, acute pain, FDA approval, opioid alternative

Gilead Withdraws Trodelvy for Bladder Cancer in US After Confirmatory Trial Failure

11 months ago talkbio0Tagged Accelerated, Approved, Carcinoma, Transitional Cell, Gilead Sciences, Malignant neoplasm of urinary bladder, Trodelvy, United States Food and Drug Administration

Gilead Sciences, Trodelvy, bladder cancer, urothelial carcinoma, FDA, accelerated approval, drug withdrawal

European Commission’s Reconsideration of Translarna’s Marketing Authorization: A Critical Turning Point for Duchenne Muscular Dystrophy Treatment

11 months ago talkbio0Tagged CHMP, Commission, Conditional, Decision, Drug Approval, European (ethnic group), Multiple Acyl Coenzyme A Dehydrogenase Deficiency, Muscular Dystrophy, Duchenne, regulatory, Translarna

Translarna, Duchenne muscular dystrophy, European Commission, EMA, CHMP, conditional marketing authorization, drug approval, regulatory decisions

FDA Approves Avadel’s Lumryz for Pediatric Narcolepsy Patients

11 months ago talkbio0Tagged Approved, Avadel, Cataplexy, Daytime Somnolence, Excessive (qualifier value), Excessive Daytime Sleepiness, LUMRYZ, Narcolepsy, Pediatric brand name, sodium oxybate, United States Food and Drug Administration

Avadel Pharmaceuticals, Lumryz, narcolepsy, pediatric patients, FDA approval, sodium oxybate, cataplexy, excessive daytime sleepiness (EDS)

FDA Approves Vyalev: A Breakthrough Continuous Infusion Therapy for Advanced Parkinson’s Disease

11 months ago talkbio0Tagged AbbVie, Approved, carbidopa, Continuous, Infusion procedures, levodopa, motor fluctuations, Parkinson Disease, United States Food and Drug Administration, Vyalev

Vyalev, Parkinson’s disease, continuous infusion therapy, FDA approval, AbbVie, motor fluctuations, levodopa, carbidopa

Bavarian Nordic’s Mpox Vaccine Demonstrates Equivalent Efficacy in Teens and Adults: NIH Study

11 months ago talkbio0Tagged Adolescent (age group), Adult, Antibodies, Bavarian Nordic, Effectiveness, mpox vaccine, MVA, MVA-BN vaccine, NIH, NIH Mouse, Response process, Safety

Mpox vaccine, Bavarian Nordic, MVA-BN vaccine, Teenagers, Adults, Antibody response, Safety, Efficacy, NIH study